The expression of CCR2b on GDH-CAR T cells enhanced trafficking to CCL2-secreting neuroblastoma 10-fold, compared to non-CCR2b-expressing CAR T cells, and increased the relative anti-tumour activity [40]. This evidence concerns the gene CCR2 and neuroblastoma.